PDF Solutions (PDFS) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue was $47.8 million, up 16% year-over-year, driven by Analytics and Integrated Yield Ramp growth, but down from $50.1 million in Q4 2024.

• Completed the $130 million acquisition of SecureWise, enhancing secure remote connectivity and expanding platform capabilities, funded by $70 million in new debt and cash.

• Non-GAAP net income was $8.1 million ($0.21 per share), up from $5.7 million ($0.15) year-over-year; GAAP net loss was $3.0 million due to $4.3 million in non-recurring acquisition costs.

• Gross margin improved to 77% non-GAAP and 73% GAAP, reflecting higher Analytics and GainShare revenues and lower costs.

• Maintained revenue growth guidance of 21%-23% for 2025, reflecting confidence in product demand and customer engagement.

Financial highlights

• Analytics revenue reached $42.5 million, up 10% year-over-year, though lower sequentially due to prior quarter's eProbe sale.

• Integrated Yield Ramp revenue grew 86% year-over-year to $5.3 million, driven by new GainShare contracts and increased customer wafer shipments.

• Operating margin was 18% non-GAAP, flat sequentially and up from 12% a year ago; GAAP operating margin was negative due to acquisition costs.

• Cash, cash equivalents, and short-term investments totaled $54 million at quarter-end, down from $115 million due to the acquisition and CapEx.

• Operating cash flow was $8.6 million, up from negative $1.9 million in Q1 2024.

Outlook and guidance

• Reaffirmed full-year revenue growth guidance of 21%-23% over 2024, ahead of the long-term 20% target.

• Expects continued IYR revenue growth and additional Sapiens Manufacturing Hub contracts in 2025.

• Anticipates exceeding DFI system shipment goals for the year.

• Management expects opportunities from Industry 4.0, cloud analytics, and secure data exchange, but notes potential headwinds from macroeconomic uncertainty, export controls, and geopolitical tensions.

• Near-term impact from expanded trade restrictions is expected to be limited, but ongoing regulatory changes could affect future sales, especially in China.